Select Page
About
Cook Biotech Acquisition
History of Innovation
Mission & Values
Leadership
Corporate Compliance
Corporate Social Responsibility
Company Credentials
Labeling
Contact Us

Cook Biotech Acquisition

Cook Biotech Acquisition

In February 2024 we expanded our portfolio with the acquisition of Cook Biotech, becoming the only CDMO in regenerative medicine with a differentiated portfolio of allograft and xenograft biomaterials at scale.

With decades of operation in the regenerative medicine field, Cook Biotech is a global leader and pioneer in developing medical solutions based on the regenerative properties of extracellular matrix materials (ECM) to produce xenografts. Based in West Lafayette, Indiana, Cook Biotech researches, processes and manufactures biomaterials that help patients overcome serious medical conditions.

The Cook Biotech team has shipped over six million products to date, specializing in over 15 clinical applications, all focused on enhancing patients’ lives by creating the best clinical outcomes and addressing patient need.

If you would like to learn more about Cook Biotech’s expertise in xenografts, click here.